Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
2021 · Nature Communications · 29 citations
https://doi.org/10.1038/s41467-021-25341-9
Y
Young Sun Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
1.2K
Citations
13
h-index
15
i10-index
Young Sun Lee is an academic researcher from San Francisco Community Clinic Consortium. The author has contributed to research in topics: Prostate Cancer Treatment and Research & PI3K/AKT/mTOR signaling in cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 13, co-authored 34 publications.
ORCID: 0000-0002-6612-7341Papers by this author
worksVisually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema
2015 · British Journal of Radiology · 22 citations
https://doi.org/10.1259/bjr.20150545
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
2025 · Science Advances · 11 citations
https://doi.org/10.1126/sciadv.adq3802
ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L
2025 · Nature Genetics · 4 citations
https://doi.org/10.1038/s41588-025-02289-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat